Recurrent/Refractory Lymphoma
1 clinical trials · Condition
◉ Watch Recurrent/Refractory Lymphoma
| Record | Firm | Date |
|---|---|---|
| Clinical Pharmacokinetics of Mitoxantrone Hydrochloride Liposome Injection in Recurrent/Refractory Lymphoma Subjects (NCT05173545) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2019-07-29 |
Track Recurrent/Refractory Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.